A physician’s education about cannabis medicine, and her patient’s treatment options, should not depend on their state of residence. Patient access should be based on sound science and physicians should receive comprehensive and uniform education regardless of the state in which they practice.
The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.
For my talk, I compared and contrasted the hemp and CBD regulatory regimes in Europe and US. Although they parallel each other in some respects, particularly policy, they are fundamentally different in their approaches.
The mouth swab drug test is commonly used by employers. Here’s what you need to know.
Governments across the world, having become familiar with the health benefits of marijuana, are now legalizing cannabis use for medical patients. As a result, medical marijuana has become more mainstream than ever in the health industry.
Although not binding law, the FDA’s Statement provides some important insights into its current view and the direction it may take with respect to hemp and CBD.
Research suggests that some cannabinoids may, in fact, increase focus, suppress appetite and keep users awake.
To say that all CBD is unlawful because it is a derivative of Cannabis is nonsensical; there are lawful and unlawful types of Cannabis.
I am not exaggerating when I say that the future of your cannabis business, and the industry at large, may depend on the outcome of this case.